These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16078861)

  • 1. Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(4):247-57. PubMed ID: 16078861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes as novel targets for cancer therapy (part III): transcription factors.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(5):327-38. PubMed ID: 16196502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(6):397-407. PubMed ID: 16336004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes as novel targets for cancer therapy (part I): growth factors and protein tyrosine kinases.
    Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
    Am J Pharmacogenomics; 2005; 5(3):173-90. PubMed ID: 15952871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a meeting: molecular basis of cancer therapy.
    Gottesman MM
    J Natl Cancer Inst; 1994 Sep; 86(17):1277-85. PubMed ID: 7914937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes are to lose control on signaling following mutation: should we aim off target?
    Hornberg JJ; Westerhoff HV
    Mol Biotechnol; 2006 Oct; 34(2):109-16. PubMed ID: 17172656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction.
    Workman P
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):611-4. PubMed ID: 12503197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer cells. Genetic anomalies (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination, prognostic impact].
    Blay JY; Puisieux A
    Rev Prat; 2000 May; 50(10):1135-44. PubMed ID: 10905101
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenic signaling pathways and deregulated target genes.
    Schäfer R; Schramme A; Tchernitsa OI; Sers C
    Recent Results Cancer Res; 2007; 176():7-24. PubMed ID: 17607912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene suppression by small interfering RNAs.
    Heidenreich O
    Curr Pharm Biotechnol; 2004 Aug; 5(4):349-54. PubMed ID: 15320765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of phospholipid intracellular signaling as antiproliferative agents.
    Powis G; Hill SR; Frew TJ; Sherrill KW
    Med Res Rev; 1995 Mar; 15(2):121-38. PubMed ID: 7739293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.
    Roth JA
    Ann Surg Oncol; 1994 Jan; 1(1):79-86. PubMed ID: 7834433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes and cancer suppressor genes.
    Yarbro JW
    Semin Oncol Nurs; 1992 Feb; 8(1):30-9. PubMed ID: 1546217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting transcription factors for cancer gene therapy.
    Libermann TA; Zerbini LF
    Curr Gene Ther; 2006 Feb; 6(1):17-33. PubMed ID: 16475943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer.
    Giuriato S; Rabin K; Fan AC; Shachaf CM; Felsher DW
    Semin Cancer Biol; 2004 Feb; 14(1):3-11. PubMed ID: 14757531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics and cancer: advances and perspectives].
    Kahn A
    Pathol Biol (Paris); 1995 Mar; 43(3):139-42. PubMed ID: 7675539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.
    Rosen EM; Fan S; Goldberg ID; Rockwell S
    Oncology (Williston Park); 2000 May; 14(5):741-57; discussion 757-8, 761-6. PubMed ID: 10853463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical pathway targeting in cancer therapy.
    Shahbazian D; Sznol J; Kluger HM
    Adv Pharmacol; 2012; 65():1-26. PubMed ID: 22959021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and signal transduction.
    Wong AJ; Croce CM
    Hosp Pract (Off Ed); 1993 Jul; 28(7):128-32, 136-8, 141. PubMed ID: 8325909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular oncogenes and cancer.
    Cooper GM
    Clin Physiol Biochem; 1987; 5(3-4):122-9. PubMed ID: 3621795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.